STOCK TITAN

Marinus Pharmaceuticals to Present at the 6th Annual Evercore ISI HealthCONx Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) announced that CEO Scott Braunstein, M.D. will participate in a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference. The event will be held on November 28 at 12:55 p.m. Eastern Time. A webcast link is available on Marinus’ website, with a replay accessible for 90 days.
Positive
  • None.
Negative
  • None.

RADNOR, Pa.--(BUSINESS WIRE)-- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that Scott Braunstein, M.D., Chairman and Chief Executive Officer, will be participating in a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference.

The fireside chat will take place on Tuesday, November 28 beginning at 12:55 p.m. Eastern Time.

A link to the event can be accessed on the Investors and Media page of Marinus’ website at ir.marinuspharma.com/events-and-presentations. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 90 days.

About Marinus Pharmaceuticals

Marinus is a commercial-stage pharmaceutical company dedicated to the development of innovative therapeutics for seizure disorders. The Company first introduced FDA-approved prescription medication ZTALMY® (ganaxolone) oral suspension CV in the U.S. in 2022 and continues to invest in the potential of ganaxolone in IV and oral formulations to maximize therapeutic reach for adult and pediatric patients in acute and chronic care settings. For more information about Marinus visit www.marinuspharma.com.

Investors

Jim DeNike

Senior Director, Investor Relations

Marinus Pharmaceuticals, Inc.

jdenike@marinuspharma.com

Media

Molly Cameron

Director, Corporate Communications & Investor Relations

Marinus Pharmaceuticals, Inc.

mcameron@marinuspharma.com

Source: Marinus Pharmaceuticals

FAQ

When is the 6th Annual Evercore ISI HealthCONx Conference fireside chat for Marinus Pharmaceuticals, Inc.?

The fireside chat is scheduled for Tuesday, November 28 at 12:55 p.m. Eastern Time.

Where can I access the webcast link for the event?

The webcast link is available on Marinus’ website at ir.marinuspharma.com/events-and-presentations.

How long will the replay of the webcast be available?

The replay of the webcast will be accessible for up to 90 days.

Who will be participating in the fireside chat at the conference?

CEO Scott Braunstein, M.D. will be participating in the fireside chat.

Marinus Pharmaceuticals, Inc

NASDAQ:MRNS

MRNS Rankings

MRNS Latest News

MRNS Stock Data

17.38M
49.03M
10.94%
83.04%
10.28%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
RADNOR